Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses

v3.7.0.1
Accrued Expenses
 6 Months Ended
Jun. 30, 2017
Payables and Accruals [Abstract]  
Accrued Expenses

7. ACCRUED EXPENSES

 

Accrued expenses consisted of the following:

 

    June 30, 2017     December 31, 2016  
             
Accrued clinical operations and trials costs   $ 1,334,054     $ 1,647,490  
Accrued product development costs     1,232,644       713,426  
Accrued compensation     28,600       778,250  
Accrued other     110,446       117,289  
Total   $ 2,705,744     $ 3,256,455